NCT02619162 2019-07-23Nintedanib+Letrozole in Postmenopausal Women With Breast Cancer: Clinical Trial Safety and PharmacodynamicsCentro Nacional de Investigaciones Oncologicas CARLOS IIIPhase 1 Completed25 enrolled
NCT02389764 2019-07-17Nintedanib For HER2-Negative Metastatic Inflammatory Breast Cancer (MIBC)M.D. Anderson Cancer CenterPhase 2 Terminated10 enrolled 9 charts